Communiqués Inspira Technologies Oxy B.H.N. Ltd.

Actions

IINN

IL0011715781

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 21/06/2024			Varia. 5j.	Varia. 1 janv.
1,34 ^USD	-4,29%		-29,47%	+26,42%

17/06	Inspira ? présente ses solutions de réanimation avancées aux principaux dirigeants internationaux lors de la conférence annuelle iECOs en Israël	CI
13/06	Inspira reçoit le tout premier bon de commande pour les systèmes Inspira Art100 aux États-Unis	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Inspira Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel	18/06	AQ
Inspira Technologies Oxy B H N : Registered Direct Offering Form 6 K	17/06	PU
Inspira Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments	31/05	AQ
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments	30/05	PR
INSPIRA ART100 Receives FDA 510(k) Clearance	29/05	AQ
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	02/04	AQ
Inspira Technologies Reports Full Year 2023 Financial Results	26/03	AQ
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	08/03	PU
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	04/03	PU
Inspira Announces Breakthrough Update, Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	28/02	AQ
Inspira to Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	28/02	AQ
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	15/02	AQ
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices	30/01	PR
Inspira Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA ART100 Device	03/01	AQ
Inspira Technologies Closes on $3.88 Million Registered Direct Offering	29/12	AQ
Inspira Technologies Oxy B H N : Report Of Foreign Private Issuer - Form 6-K	29/12	PU
Inspira Announces 95% Accuracy Results for HYLA Blood Sensor, Planning FDA Submission for Clearance in 2024	27/12	AQ
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	22/11	PU
Inspira Technologies Oxy B H N : Current Report - Form 6-K	13/11	PU
Inspira Technologies Oxy B H N : ™ Granted U.S. Patent for ™ ART500 Medical Device - Form 6-K	25/10/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Inspira Technologies Oxy B.H.N. Ltd.

Actions

IINN

IL0011715781

Communiqués

Filtres